L S Caplan1, D S May, L C Richardson. 1. Epidemiology and Health Services Research Branch, Centers for Disease Control and Prevention, Atlanta, Ga. 30341, USA. lhc9@cdc.gov
Abstract
OBJECTIVES: This study examined times to diagnosis and treatment for medically underserved women screened for breast cancer. METHODS: Intervals from first positive screening test to diagnosis to initiation of treatment were determined for 1659 women 40 years and older diagnosed with breast cancer. RESULTS: Women with abnormal mammograms had shorter diagnostic intervals than women with abnormal clinical breast examinations and normal mammograms. Women with self-reported breast symptoms had shorter diagnostic intervals than asymptomatic women. Diagnostic intervals were less than 60 days in 78% of cases. Treatment intervals were generally 2 weeks or less. CONCLUSIONS: Most women diagnosed with breast cancer were followed up in a timely manner after screening. Further investigation is needed to identify and then address factors associated with longer diagnostic and treatment intervals to maximize the benefits of early detection.
OBJECTIVES: This study examined times to diagnosis and treatment for medically underserved women screened for breast cancer. METHODS: Intervals from first positive screening test to diagnosis to initiation of treatment were determined for 1659 women 40 years and older diagnosed with breast cancer. RESULTS:Women with abnormal mammograms had shorter diagnostic intervals than women with abnormal clinical breast examinations and normal mammograms. Women with self-reported breast symptoms had shorter diagnostic intervals than asymptomatic women. Diagnostic intervals were less than 60 days in 78% of cases. Treatment intervals were generally 2 weeks or less. CONCLUSIONS: Most women diagnosed with breast cancer were followed up in a timely manner after screening. Further investigation is needed to identify and then address factors associated with longer diagnostic and treatment intervals to maximize the benefits of early detection.
Authors: Roger T Anderson; Cyllene R Morris; Gretchen Kimmick; Amy Trentham-Dietz; Fabian Camacho; Xiao-Cheng Wu; Susan A Sabatino; Steven T Fleming; Joseph Lipscomb Journal: Cancer Date: 2014-11-04 Impact factor: 6.860
Authors: Susan N Lukwago; Matthew W Kreuter; Cheryl L Holt; Karen Steger-May; Dawn C Bucholtz; Celette Sugg Skinner Journal: Am J Public Health Date: 2003-08 Impact factor: 9.308
Authors: Kathleen Ell; Betsy Vourlekis; Jan Nissly; Deborah Padgett; Diana Pineda; Olga Sarabia; Virginia Walther; Susan Blumenfield; Pey-jiuan Lee Journal: Community Ment Health J Date: 2002-08
Authors: Oluwadamilola M Fayanju; Donna B Jeffe; Jennifer R Tappenden; Courtney E Beers; Bettina F Drake; Feng Gao; Julie A Margenthaler Journal: Mo Med Date: 2012 Sep-Oct
Authors: Richard G Roetzheim; Ji-Hyun Lee; Ercilia R Calcano; Cathy D Meade; William J Fulp; Kristen J Wells Journal: J Health Care Poor Underserved Date: 2012-08
Authors: Karen M Freund; Tracy A Battaglia; Elizabeth Calhoun; Donald J Dudley; Kevin Fiscella; Electra Paskett; Peter C Raich; Richard G Roetzheim Journal: Cancer Date: 2008-12-15 Impact factor: 6.860
Authors: Lisa C Richardson; Janet Royalty; William Howe; William Helsel; William Kammerer; Vicki B Benard Journal: Am J Public Health Date: 2009-12-17 Impact factor: 9.308
Authors: Tracy A Battaglia; M Christina Santana; Sharon Bak; Manjusha Gokhale; Timothy L Lash; Arlene S Ash; Richard Kalish; Stephen Tringale; James O Taylor; Karen M Freund Journal: Cancer Date: 2010-02-15 Impact factor: 6.860
Authors: Marc A Emerson; Yvonne M Golightly; Allison E Aiello; Katherine E Reeder-Hayes; Xianming Tan; Ugwuji Maduekwe; Marian Johnson-Thompson; Andrew F Olshan; Melissa A Troester Journal: Cancer Date: 2020-09-21 Impact factor: 6.860